Prosecution Insights
Prosecution Insights
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (57%) |
| Double-patenting + other | 1 (14%) |
| No statute on record | 2 (29%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAMA, JOANNE | 1 | 23.9% | +35.4% |
| SWIFT, CANDICE LEE | 1 | 58.3% | +38.5% |
| CANDELARIA, JULIANA IRENE | 1 | — | — |
| BRADLEY, CHRISTINA | 1 | 62.7% | +33.2% |
| LIEB, JEANETTE M | 1 | 80.0% | +16.7% |
| CHANDRA, GYAN | 1 | 71.1% | +27.7% |
| HILL, KEVIN KAI | 1 | 36.2% | +33.4% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18150983 | METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS | LIEB, JEANETTE M | 146d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18360542 | COMBINATION THERAPIES FOR TREATMENT OF CANCER | HAMA, JOANNE | 42d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18150983 | METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS | LIEB, JEANETTE M | 146d overdue |
| 18001637 | DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPEUTIC | SWIFT, CANDICE LEE | 28d overdue |
| 18177387 | OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS | BRADLEY, CHRISTINA | 23d overdue |
| 17783463 | Compositions and Methods of Treating Cancer with Chimeric Antigen Receptors Targeting Glypican 3 | HILL, KEVIN KAI | 3d overdue |
| 18360542 | COMBINATION THERAPIES FOR TREATMENT OF CANCER | HAMA, JOANNE | 42d |
| 17801670 | FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES | CHANDRA, GYAN | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1647 | 1 |
| 1657 | 1 |
| 1634 | 1 |
| 1674 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18360542 | COMBINATION THERAPIES FOR TREATMENT OF CANCER | HAMA, JOANNE | 1647 | Other | Non-Final OA | 42d | Pending | Jul 27, 2023 |
| 18001637 | DETERGENT AND METHOD FOR PURIFYING A BIOTHERAPEUTIC | SWIFT, CANDICE LEE | 1657 | §103 | Final Rejection | 28d overdue | Pending | Jul 14, 2023 |
| 18351821 | METHODS FOR EXPANDING T CELL POPULATIONS | CANDELARIA, JULIANA IRENE | 1634 | DPOther | Non-Final OA | 60d | Pending | Jul 13, 2023 |
| 18177387 | OPTIMIZED RATIOS OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS CONTAINING HIGH CONCENTRATIONS OF PROTEIN-BASED THERAPEUTIC AGENTS | BRADLEY, CHRISTINA | 1654 | §103 | Final Rejection | 23d overdue | Pending | Mar 02, 2023 |
| 18150983 | METHOD OF PURIFYING ALBUMIN-FUSION PROTEINS | LIEB, JEANETTE M | 1654 | §103 | Non-Final OA | 146d overdue | Pending | Jan 06, 2023 |
| 17801670 | FORMULATIONS OF ANTI-ENDOTHELIAL LIPASE ANTIBODIES | CHANDRA, GYAN | 1674 | §103 | Final Rejection | — | Pending | Aug 23, 2022 |
| 17783463 | Compositions and Methods of Treating Cancer with Chimeric Antigen Receptors Targeting Glypican 3 | HILL, KEVIN KAI | 1638 | Other | Non-Final OA | 3d overdue | Pending | Jun 08, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial